JP2025513720A5 - - Google Patents
Info
- Publication number
- JP2025513720A5 JP2025513720A5 JP2024556457A JP2024556457A JP2025513720A5 JP 2025513720 A5 JP2025513720 A5 JP 2025513720A5 JP 2024556457 A JP2024556457 A JP 2024556457A JP 2024556457 A JP2024556457 A JP 2024556457A JP 2025513720 A5 JP2025513720 A5 JP 2025513720A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- recombinant polypeptide
- domain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22164122.8 | 2022-03-24 | ||
| EP22164122 | 2022-03-24 | ||
| PCT/EP2023/057679 WO2023180546A1 (en) | 2022-03-24 | 2023-03-24 | Mho ib-mediated myelin-specific immunosuppression as a novel treatment for multiple sclerosis and mog antibody disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025513720A JP2025513720A (ja) | 2025-04-30 |
| JP2025513720A5 true JP2025513720A5 (https=) | 2026-03-12 |
Family
ID=81389016
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024556457A Pending JP2025513720A (ja) | 2022-03-24 | 2023-03-24 | 多発性硬化症及び抗ＭＯＧ抗体性疾患のための新規治療法としてのＭＨＣ Ｉｂ仲介ミエリン特異的免疫抑制 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20250222083A1 (https=) |
| EP (1) | EP4499676A1 (https=) |
| JP (1) | JP2025513720A (https=) |
| KR (1) | KR20240162578A (https=) |
| CN (1) | CN118922435A (https=) |
| AU (1) | AU2023240382A1 (https=) |
| CA (1) | CA3255287A1 (https=) |
| CL (1) | CL2024002837A1 (https=) |
| CO (1) | CO2024013220A2 (https=) |
| IL (1) | IL315510A (https=) |
| MX (1) | MX2024011667A (https=) |
| WO (1) | WO2023180546A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025061913A1 (en) * | 2023-09-22 | 2025-03-27 | Julius-Maximilians-Universität Würzburg | Mhc ib-mediated myelin-specific immunosuppression as a novel treatment for multiple sclerosis and mog antibody disease |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3630809A1 (en) | 2017-05-23 | 2020-04-08 | Bruttel, Valentin | Combinations of mhc class ib molecules and peptides for targeted therapeutic immunomodulation |
| US11464840B2 (en) * | 2018-02-26 | 2022-10-11 | Swey-Shen Chen | Universal non-classical MHC I vaccines: HLA-E-restricted antigenic peptides as universal vaccines to treat allergy, inflammation, autoimmune and infectious diseases, and cancers |
-
2023
- 2023-03-24 AU AU2023240382A patent/AU2023240382A1/en active Pending
- 2023-03-24 MX MX2024011667A patent/MX2024011667A/es unknown
- 2023-03-24 CN CN202380029746.2A patent/CN118922435A/zh active Pending
- 2023-03-24 WO PCT/EP2023/057679 patent/WO2023180546A1/en not_active Ceased
- 2023-03-24 KR KR1020247035560A patent/KR20240162578A/ko active Pending
- 2023-03-24 JP JP2024556457A patent/JP2025513720A/ja active Pending
- 2023-03-24 EP EP23717409.9A patent/EP4499676A1/en active Pending
- 2023-03-24 IL IL315510A patent/IL315510A/en unknown
- 2023-03-24 US US18/849,114 patent/US20250222083A1/en active Pending
- 2023-03-24 CA CA3255287A patent/CA3255287A1/en active Pending
-
2024
- 2024-09-23 CL CL2024002837A patent/CL2024002837A1/es unknown
- 2024-09-30 CO CONC2024/0013220A patent/CO2024013220A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Mézière et al. | In vivo T helper cell response to retro-inverso peptidomimetics | |
| KR101902029B1 (ko) | 감염성 질환, 자가면역 질환, 동종인자에 대한 면역 반응, 알레르기 질환, 종양, 이식편 거부 및 유전자 요법 또는 유전자 백신접종을 위해 사용되는 바이러스 벡터에 대한 면역 반응의 예방 및/또는 치료에 사용하기 위한 면역원성 펩티드 | |
| TWI608099B (zh) | 用於活化細胞毒性ｔ細胞的方法及組成物，及用於細胞毒性ｔ細胞之活化誘導物 | |
| JP2023524054A5 (https=) | ||
| JP2015521467A5 (https=) | ||
| JP2020521000A5 (https=) | ||
| US20160060358A1 (en) | Induction of antigen-specific tolerance | |
| RU2011125306A (ru) | Праймирование иммунного ответа | |
| TW202130363A (zh) | 變異型ｒｓｖ ｆ蛋白質及其利用 | |
| TW200902049A (en) | Fusion protein | |
| CN115702162A (zh) | 用于治疗多发性硬化的肽和方法 | |
| AU2006259041B2 (en) | Agents and methods based on the use of the EDA domain of fibronectin | |
| JPH07503362A (ja) | レコンビトープペプチド | |
| Falk et al. | Induction and suppression of an autoimmune disease by oligomerized T cell epitopes: enhanced in vivo potency of encephalitogenic peptides | |
| JP2025513720A5 (https=) | ||
| CN100467063C (zh) | 一类免疫佐剂及其在抗病毒疫苗或药物制备中的应用 | |
| JP2025510786A5 (https=) | ||
| CN118891059A (zh) | 嵌合多肽 | |
| CN118946367A (zh) | 嵌合多肽 | |
| CN118922203A (zh) | 嵌合多肽 | |
| JP2025514872A5 (https=) | ||
| US5000952A (en) | Polypeptide pertussis toxin vaccine | |
| EP1355922A2 (en) | Stress proteins and peptides and methods of use thereof | |
| AU2001285427A1 (en) | Stress proteins and peptides and methods of use thereof | |
| Unanue et al. | The immunoregulatory role of the macrophage |